-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GLesi7CTbPHI0QSaCDN2H3JDquESKiN/3IAwjxb3H7M7IBKfMvc1u8bjI1dMxMxH bUu0EAxm7V/+XWBYKOWyfA== 0001181431-06-025582.txt : 20060427 0001181431-06-025582.hdr.sgml : 20060427 20060427101301 ACCESSION NUMBER: 0001181431-06-025582 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060425 ITEM INFORMATION: Other Events FILED AS OF DATE: 20060427 DATE AS OF CHANGE: 20060427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 041406317 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 06783417 BUSINESS ADDRESS: STREET 1: 7711 CARONDELET AVE CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7711 CARONDELET AVE STREET 2: SUITE 800 CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 rrd115456.htm Prepared By R.R. Donnelley Financial -- Form 8-K
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 8-K
 
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  04/25/2006
 
Centene Corporation
(Exact name of registrant as specified in its charter)
 
Commission File Number:  000-33395
 
Delaware
  
42-1406317
(State or other jurisdiction of
  
(IRS Employer
incorporation)
  
Identification No.)
 
7711 Carondelet Avenue, Suite 800, St. Louis, MO 63105
(Address of principal executive offices, including zip code)
 
314-725-4477
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

Information to be included in the report

 
Item 8.01.    Other Events
 
On April 25, 2006, we held our annual meeting of stockholders. At the meeting, Frederick H. Eppinger was elected to the board of directors for a three year term. Current directors, Robert K. Ditmore and David L. Steward were also elected for new three year terms. Additionally, our stockholders ratified the selection of KPMG LLP to serve as our independent registered public accounting firm for the fiscal year ended December 31, 2006.

Also on April 25, 2006, our board of directors, at its annual meeting, elected our senior management team consisting of:

Michael F. Neidorff, Chairman, President and Chief Executive Officer

J. Per Brodin, Senior Vice President and Chief Financial Officer, Secretary and Treasurer
Joseph P. Drozda, Jr., M.D., Executive Vice President and Chief Medical Officer
Marie J. Glancy, Senior Vice President, Operational Services and Regulatory Affai rs
Carol E. Goldman, Senior Vice President and Chief Administrative Officer
Cary D. Hobbs, Senior Vice President, Strategy and Business Implementation
Robert C. Packman, M.D., Senior Vice President, Medical Affairs
William N. Scheffel, Senior Vice President and Chief Executive, Specialty Business Unit
Glendon A. Schuster, Senior Vice President and Chief Information Officer
Joy D. Wheeler, Senior Vice President, Health Plan Business Unit Development
Lisa M. Wilson, Senior Vice President, Investor Relations
Karey L. Witty, Senior Vice President and Chief Executive, Health Plan Business Unit
 

 

Signature(s)
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
      
 
Centene Corporation
 
 
Date: April 27, 2006
     
By:
 
/s/    J. Per Brodin
               
J. Per Brodin
               
Senior Vice President and Chief Financial Officer, Secretary and Treasurer
 
 
 -----END PRIVACY-ENHANCED MESSAGE-----